Get the Stockscreener App
4.33
2.26%
-0.10
Lifecore Biomedical Inc stock is traded at $4.33, with a volume of 106.83K.
It is down -2.26% in the last 24 hours and down -25.34% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$4.43
Open:
$4.45
24h Volume:
106.83K
Relative Volume:
0.52
Market Cap:
$162.42M
Revenue:
$147.12M
Net Income/Loss:
$-33.88M
P/E Ratio:
-9.0114
EPS:
-0.4805
Net Cash Flow:
$-13.62M
1W Performance:
-7.48%
1M Performance:
-25.34%
6M Performance:
-49.53%
1Y Performance:
-41.09%
1-Day Range:
$4.31
$4.575
1-Week Range:
$4.31
$4.9599
52-Week Range:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
4.33 | 162.42M | 147.12M | -33.88M | -13.62M | -0.4805 |
TAK
Takeda Pharmaceutical Co Adr
|
17.24 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.78 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.81 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.35 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
528.47 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
View All
Lifecore Biomedical Inc Stock (LFCR) Latest News
Lifecore Biomedical (LFCR) Q1 2026 earnings summary - Quartr
Lifecore Biomedical (LFCR) Proxy filing Summary - Quartr
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm
What Triggered Lifecore Biomedical's Recent Stock Plunge - Kavout | AI
New Lifecore Hire Gets 3,500 Stock Units Vesting in Three Years - Stock Titan
Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market - Yahoo Finance
Lifecore Biomedical (LFCR) AGM 2026 Summary - Quartr
Lifecore Biomedical (LFCR) Q2 2024 earnings summary - Quartr
Lifecore Biomedical (LFCR) Q3 2024 earnings summary - Quartr
Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: Deep EPS Miss Highlights Operational DifficultiesFull Year Guidance - dars.gov.et
Lifecore Biomedical (LFCR) Gains 3.17% as Stock Tests Key Resistance at $4.95FRAMA Signal - dars.gov.et
Lifecore Biomedical Inc. (LFCR) Drops Nearly 6% as Stock Tests Key Support LevelsFloat Adjusted Cap - dars.gov.et
Lifecore Biomedical (LFCR) Slips 3.17%: Testing Key Support at $4.65WMA Signal - dars.gov.et
LFCR Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesGross Profit Margin - dars.gov.et
LFCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEarnings Risk Report - DonanımHaber
Lifecore Biomedical (LFCR) Stock Forum and Discussion - Moomoo
Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India
Form 13D/A Lifecore Biomedical For: 2 July By Investing.com - Investing.com Nigeria
Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView
Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan
[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan
(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Lifecore Biomedical’s New Collaborations May Strengthen Long-Term Value ProspectsDownward Estimate Revision - dars.gov.et
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance
Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review
12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey
Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView
Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Enterprise value to EBIT forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView
LFCR Forecast — Price Target — Prediction for 2027 - TradingView
LDE Forecast — Price Target — Prediction for 2027 - TradingView
Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesOperating Margin Analysis - DonanımHaber
How (LFCR) Movements Inform Risk Allocation Models - Stock Traders Daily
LFCR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock Edges HigherAnnual Report - dars.gov.et
Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):